Home
>
Algae
>
microalgae
>
Schizochytrium sp. DHA/EPA Omega-3
Schizochytrium sp. DHA/EPA Omega-3
Capsules
Food icon
Feed icon
Pharma icon
Cosmetics icon
Fashion icon
Agriculture icon

Schizochytrium sp. DHA/EPA Omega-3

  • Content ratio of 3:1 or 2:1 of DHA/EPA

Delivery time
On Demand weeks
Quality by Alganex - icon

Why are DHA and EPA from microalgae important?

DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid) are essential omega-3 fatty acid and must be absorbed by the human body for stable health[3, 6]. Vegan DHA/EPA capsules from microalgae offer a unique alternative to fish oil capsules. 

 

Typical applications: Schizochytrium sp. DHA/EPA Omega-3

typical applications for Schizochytrium sp. DHA/EPA Omega-3 Capsules

Typical applications

  • DHA/EPA capsules are used as a food supplement
  • The capsules from the microalgae Schizochytrium sp. offer a unique alternative to the usual fish oil
certification Alganex icon

ALGANEX certificate system

  • ALGANEX guarantees a high quality product without impurities.
  • The DHA/EPA comes 100% from Schizochytrium sp.
  • The DHA/EPA content is min. 500 mg (3:1 ratio).

Product information: Schizochytrium sp. DHA/EPA Omega-3

DHA (docosahexaenoic acid) is an omega-3 fatty acid and is particularly important for vision and brain development as well as for the development of the central nervous system of unborn and newborn humans and animals[4, 5, 7]. The EU committee recommends omega-3 supplements during pregnancy in order to improve childhood development.

EPA (eicosapentaenoic acid) is also an omega-3 fatty acid and is particulary known for its positive effects on processes within the organism. Besides its main ability to reduce inflammation and pain, EPA can be used for heart-related conditions, menstrual problems and even some personality disorders[8, 9, 10]. 

Our product is suitable for vegetarian and vegan nutrition.

 

 

Sources:

  1. Schizochytrium - M.D. Guiry in Guiry, M.D. & Guiry, G.M. 16 March 2016. AlgaeBase. World-wide electronic publication, National University of Ireland, Galway. (https://www.algaebase.org/search/genus/detail/?genus_id=51398)
  2. Schizochytrium - Wikipedia (https://en.wikipedia.org/wiki/Schizochytrium)
  3. Zhang TT, Xu J, Wang YM, Xue CH. Health benefits of dietary marine DHA/EPA-enriched glycerophospholipids. Prog Lipid Res. 2019 Jul;75:100997. doi: 10.1016/j.plipres.2019.100997. Epub 2019 Aug 20. PMID: 31442526. (https://pubmed.ncbi.nlm.nih.gov/31442526/)
  4. Lauritzen L, Brambilla P, Mazzocchi A, Harsløf LB, Ciappolino V, Agostoni C. DHA Effects in Brain Development and Function. Nutrients. 2016 Jan 4;8(1):6. doi: 10.3390/nu8010006. PMID: 26742060; PMCID: PMC4728620. (https://pubmed.ncbi.nlm.nih.gov/26742060/)
  5. Djuricic I, Calder PC. Pros and Cons of Long-Chain Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Health. Annu Rev Pharmacol Toxicol. 2023 Jan 20;63:383-406. doi: 10.1146/annurev-pharmtox-051921-090208. PMID: 36662586. (https://pubmed.ncbi.nlm.nih.gov/36662586/)
  6. Swanson D, Block R, Mousa SA. Omega-3 fatty acids EPA and DHA: health benefits throughout life. Adv Nutr. 2012 Jan;3(1):1-7. doi: 10.3945/an.111.000893. Epub 2012 Jan 5. PMID: 22332096; PMCID: PMC3262608. (https://pubmed.ncbi.nlm.nih.gov/22332096/)
  7. Horrocks LA, Yeo YK. Health benefits of docosahexaenoic acid (DHA). Pharmacol Res. 1999 Sep;40(3):211-25. doi: 10.1006/phrs.1999.0495. PMID: 10479465. (https://pubmed.ncbi.nlm.nih.gov/10479465/)
  8. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002 Dec;21(6):495-505. doi: 10.1080/07315724.2002.10719248. PMID: 12480795. (https://pubmed.ncbi.nlm.nih.gov/12480795/)
  9. Mano Y, Kato A, Fukuda N, Yamada K, Yanagimoto K. Influence of Ingestion of Eicosapentaenoic Acid-Rich Fish Oil on Oxidative Stress at the Menstrual Phase: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial. Womens Health Rep (New Rochelle). 2022 Jul 13;3(1):643-651. doi: 10.1089/whr.2022.0003. PMID: 35982775; PMCID: PMC9380882. (https://pubmed.ncbi.nlm.nih.gov/35982775/)
  10. Bellino S, Bozzatello P, Rocca G, Bogetto F. Efficacy of omega-3 fatty acids in the treatment of borderline personality disorder: a study of the association with valproic acid. J Psychopharmacol. 2014 Feb;28(2):125-32. doi: 10.1177/0269881113510072. Epub 2013 Nov 5. PMID: 24196948. (https://pubmed.ncbi.nlm.nih.gov/24196948/)
Schizochytrium sp. DHA/EPA Omega-3 > request

Reply within twelve hours